Supernus Pharmaceuticals | SUPN - Stock


Supernus Pharmaceuticals reported $110.77M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
ANI Pharmaceuticals USD 143.47M 401K Mar/2026
Aurora Cannabis CAD 230.56M 8.6M Dec/2025
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Canopy Growth CAD 105.56M 3.18M Dec/2025
Cara Therapeutics USD 900K 0 Mar/2025
Corcept Therapeutics USD 12.89M 22K Mar/2026
Eisai JPY 236.46B 9.14B Sep/2025
Eli Lilly USD 14.53B 785M Mar/2026
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Pacira USD 150.37M 2.49M Mar/2026
Perrigo USD 1.12B 27.6M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
United Therapeutics USD 178.3M 4.8M Mar/2026
Xeris Pharmaceuticals USD 74.23M 5.56M Mar/2026